Kawai · Molecular therapy : the journal of the American Society of Gene Therapy 2026 · in vitro cell culture and protocol development study · n=?

Feeder-free generation of iPSC-derived CD4 single-positive helper T cells via stage-specific modulation of Notch and TCR signaling.

Cited 2 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

In vitro laboratory study with no clinical or human participant data.

PubMed 41566778 · doi:10.1016/j.ymthe.2026.01.020 · record verified 2026-08-26

What was done

The authors developed an in vitro, feeder-free differentiation protocol to generate CD4 single-positive helper T cells from human induced pluripotent stem cells (iPSCs). The method excluded early T-cell receptor (TCR) signaling to prevent cytotoxic lineage bias and utilized stage-specific modulation of Notch and integrin signaling. Differentiated cells were assessed for expression of helper markers (CD40L, ThPOK), dendritic cell maturation capacity, proliferative durability, and phenotype changes following repeated expansion.

What was found

The abstract reports no numerical data, yields, or statistical comparisons. Qualitatively, the feeder-free system successfully generated CD4 single-positive iPSC-derived T cells that expressed CD40L and ThPOK and induced dendritic cell maturation. Repeated expansion preserved robust proliferation while also inducing cytotoxic activity in the helper T cells.

Why it matters

Generating CD4+ helper T cells under feeder-free conditions has been a key bottleneck compared to CD8+ cytotoxic T cells. This method offers a scalable framework for generating both lineages from stem cells for cell-based immunotherapies.

Limits

This is purely in vitro bench research with no in vivo validation described in the abstract. Quantitative differentiation efficiency, purity, sample sizes, and the functional consequences of CD4+ T cells acquiring cytotoxic properties post-expansion were not quantified in the abstract.

Cited by